iTeos Therapeutics, Inc.
-
Ticker
ITOS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Cambridge, Massachusetts
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s
…More innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
iTeos Therapeutics, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social and Governance Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived iTeos Therapeutics, Inc. Sustainability Report, iTeos Therapeutics, Inc. Corporate Social Responsibility Report, iTeos Therapeutics, Inc. CSR Report, iTeos Therapeutics, Inc. Corporate Responsibility, iTeos Therapeutics, Inc. CR Report, iTeos Therapeutics, Inc. Citizenship Report, iTeos Therapeutics, Inc. ESG Report, and iTeos Therapeutics, Inc. Environmental Report online.